**Core Concept**
Malaria in pregnancy poses a significant risk to both the mother and the fetus, requiring prompt and effective treatment to prevent complications such as maternal anemia, low birth weight, and even fetal loss. The management of malaria in pregnancy involves the use of antimalarial drugs that are safe for both the mother and the fetus.

**Why the Correct Answer is Right**
The next line of management for malaria in pregnancy is the administration of Artemether-Lumefantrine (Coartem). This combination antimalarial drug is recommended by the World Health Organization (WHO) as the first-line treatment for uncomplicated malaria in pregnant women. Artemether-Lumefantrine works by inhibiting the growth and replication of the malaria parasite in the liver and blood, thereby reducing the risk of complications. The drug is also effective against the most common species of malaria parasites that cause disease in humans, such as Plasmodium falciparum.

**Why Each Wrong Option is Incorrect**
**Option A:** Quinine is an older antimalarial drug that was previously used to treat malaria in pregnancy. However, it is associated with a higher risk of maternal anemia and low birth weight, making it a less desirable option.

**Option B:** Chloroquine is an antimalarial drug that is no longer effective against the most common species of malaria parasites that cause disease in humans. It is not recommended for the treatment of malaria in pregnancy.

**Option C:** Fansidar (Sulfadoxine-Pyrimethamine) is an antimalarial drug that is sometimes used to treat malaria in pregnancy. However, it is not recommended as a first-line treatment due to concerns about resistance and potential side effects.

**Clinical Pearl / High-Yield Fact**
Malaria in pregnancy is a leading cause of maternal and fetal morbidity and mortality in many parts of the world. Prompt and effective treatment with Artemether-Lumefantrine is critical to preventing complications.

**Correct Answer:** C.